Package Leaflet: Information for the User
Prolutex 25 mg solution for injection in pre-filled syringe
progesterone
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack
Prolutex contains the active substance progesterone. Progesterone is a natural female sex hormone. The medicine works on the lining of the uterus and helps it to stay and remain pregnant.
Prolutex is indicated for women who need extra progesterone while undergoing treatment in an Assisted Reproduction Technique (ART) protocol, and who cannot use or tolerate vaginal preparations.
Do not use Prolutex
Warnings and precautions
Be careful with Prolutex
If you experience any of the following disorders during treatment, tell your doctor immediately, as you may need to interrupt treatment. Also, tell your doctor immediately if you experience them a few days after the last dose:
Before treatment with Prolutex
Before treatment with Prolutex, tell your doctor if you have or have had any of the following health problems:
If this is the case, your doctor will closely monitor you during treatment.
Children and adolescents
This medicine must not be used in children or adolescents.
Other medicines and Prolutex
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those without a prescription or herbal medicines. Some medicines may interact with Prolutex. For example:
Do not administer Prolutex at the same time as another injectable medicine.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Driving and using machines
Do not drive or use tools or machines if you feel drowsy and/or dizzy while using Prolutex.
Prolutex contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per dose; it is essentially "sodium-free".
Follow your doctor's instructions for administering this medicine exactly. If you are unsure, consult your doctor again. Remember, Prolutex should only be used under the supervision of a doctor with experience in treating fertility problems.
What dose of Prolutex should you use and for how long?
The recommended dose is one daily injection of 25 mg, usually up to 12 weeks after confirmed pregnancy (i.e., 10 weeks of treatment).
How should Prolutex be administered
Prolutex should be administered under the skin (subcutaneous injection, i.e., SC).
You may self-administer 25 mg of Prolutex, subcutaneously, after receiving adequate advice and training from your doctor or healthcare professional.
Before self-administering an injection of Prolutex, you will receive the following training and advice:
Read the instructions below on preparing and administering Prolutex.
The steps to follow for correct self-administration are:
These steps are explained in detail below.
It is essential to keep everything as clean as possible, so start by washing your hands thoroughly and drying them with a clean towel. Choose a clean area to prepare the injection.
The following materials are notsupplied with your medicine. Your doctor or pharmacist will provide these materials.
Using a darting motion, insert the needle into the skin so that the skin and needle form a right angle. |
Each pre-filled syringe is for single use only.
If you use more Prolutex than you should
If you have used more Prolutex than you should, consult your doctor or pharmacist immediately. Symptoms of an overdose include numbness.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 915 620 420, indicating the medicine and the amount used.
If you forget to use Prolutex
Use the dose as soon as you remember and then proceed as before. Do not use a double dose to make up for the forgotten dose. Inform your doctor of what you have done.
If you stop treatment with Prolutex
Do not stop using Prolutex without consulting your doctor or pharmacist first. Stopping Prolutex suddenly may cause an increase in anxiety, irritability, and increase the risk of having seizures (attacks).
If you have any other questions about using this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop taking this medicine and seek medical help immediately if you have any of the following symptoms:
Very common:may affect more than 1 in 10 people
Common:may affect up to 1 in 10 people
Uncommon:may affect up to 1 in 100 people
Rare:frequency cannot be estimated from the available data
The following disorders, although not reported by patients in clinical studies using Prolutex, have been described with other progestins: insomnia, premenstrual syndrome or menstrual disorders, urticaria, acne, excessive hair growth, hair loss (alopecia), and weight gain.
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Monitoring System: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not refrigerate or freeze.
Store in the original packaging to protect from light.
Do not use this medicine after the expiration date shown on the carton and on the label of the pre-filled syringe after EXP.
Do not use this medicine if you notice particles in the solution or if the solution is not clear.
Each pre-filled syringe is for single use only.
Medicines should not be disposed of via wastewater or household waste. Dispose of the packaging and any unused medicine in the pharmacy's SIGRE collection point. If you are unsure, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Composition of Prolutex
The active substance is progesterone. Each pre-filled syringe (1.112 ml) contains 25 mg of progesterone (22.48 mg/ml).
The other ingredients are hydroxypropylbetadex, disodium phosphate, sodium dihydrogen phosphate dihydrate, and water for injections.
Appearance and packaging of the product
Prolutex is a clear and transparent solution for injection in a pre-filled syringe, supplied in a glass syringe.
Each carton contains 7 or 14 pre-filled syringes. Only certain pack sizes may be marketed.
Marketing authorisation holder and manufacturer:
IBSA Farmaceutici Italia Srl
Via Martiri di Cefalonia 2
26900 Lodi
Italy
You can obtain further information on this medicine by contacting the local representative of the marketing authorisation holder:
Instituto Bioquimico Iberico IBSA S.L.
Avenida Diagonal 605,
Planta 8, Local 1,
08028 Barcelona (Spain)
This medicine is authorised in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names (the concentration and pharmaceutical form are identical in all countries, only the trade name differs):
Austria: Progedex
Belgium: Inprosub
Bulgaria: Prolutex
Cyprus: Prolutex
Czech Republic: Prolutex
Denmark: Prolutex
Estonia: Lubion
Finland: Prolutex
France: Progiron
Germany: Prolutex
Greece: Prolutex
Hungary: Prolutex
Italy: Pleyris
Lithuania: Lubion
Latvia: Lubion
Luxembourg: Inprosub
Norway: Prolutex
Poland: Prolutex
Portugal: Prolutex
Romania: Prolutex
Slovakia: Prolutex
Sweden: Prolutex
Netherlands: Prolutex
United Kingdom (Northern Ireland): Lubion
Date of last revision of this leaflet:May 2025
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).